Acquired carbapenemases

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 6, 1997, Pages 673-676

  Livermore, David M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; IMIPENEM; MEROPENEM; PANIPENEM; UNCLASSIFIED DRUG;

ACINETOBACTER; AEROMONAS; ANTIBIOTIC RESISTANCE; BACILLUS CEREUS; BACTERIAL MUTATION; BACTEROIDES FRAGILIS; DRUG HYDROLYSIS; DRUG STABILITY; ENTEROBACTERIACEAE; FLAVOBACTERIUM; LEGIONELLA; NONHUMAN; PERMEABILITY; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; STENOTROPHOMONAS MALTOPHILIA;

ACINETOBACTER; BACILLUS CEREUS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CELL CYCLE PROTEINS; ENDOPEPTIDASES; ENTEROBACTER CLOACAE; FUNGAL PROTEINS; IMIPENEM; PROTEIN KINASES; PSEUDOMONAS AERUGINOSA; SACCHAROMYCES CEREVISIAE PROTEINS; SERRATIA MARCESCENS; THIENAMYCINS;

EID: 0030876078     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.6.673     Document Type: Short Survey

References (32)

1. Livermore, D. M. (1996). Are all β-lactams created equal? Scandinavian Journal of Infectious Diseases, Suppl. 101, 33-43.
2. Livermore, D. M. (1992). Interplay of impermeability and chromosomal β-lactamase in imipenem-resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 36, 2046-8.
3. Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. & Bush, K. (1996). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated Ampc β-lactamase, and the loss of an outer membrane protein. Antimicrobial Agents and Chemotherapy 41, 563-9.
4. Lee, E. H., Nicolas, M. H., Kitzis, M. D., Pialoux, G., Collatz, E. & Guttman, L. (1991). Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrobial Agents and Chemotherapy 35, 1093-8.
5. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, 557-84.
6. Rasmussen, B. A. & Bush, K. (1997). Carbapenem-hydrolyzing β-lactamases. Antimicrobial Agents and Chemotherapy 41, 223-32.
7. Rasmussen, B. A., Bush, K. & Tally, F. P. (1993). Antimicrobial resistance in Bacteroides. Clinical Infectious Diseases 16, Suppl. 4, S390-S400.
8. Bandoh, K., Watanabe, K., Muto, Y., Tanaka, Y., Kato, N. & Uneo, K. (1992). Conjugal transfer of imipenem resistance in Bacteroides fragilis. Journal of Antibiotics (Tokyo) 45, 542-7.
9. Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H. et al. (1994). Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrobial Agents and Chemotherapy 39, 71-8.
10. Watanabe, M., Iyobe, S., Inoue, M. & Mitsuhashi, S. (1991). Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 35, 147-51.
11. Minami, S., Araki, H., Yasuda, T., Akama, M., Iyobe, S. & Mitsuhashi, S. (1993). High level imipenem resistance associated with imipenem-hydrolyzing beta-lactamase production and outer membrane alteration in a clinical isolate of Pseudomonas aeruginosa. International Journal of Experimental and Clinical Chemotherapy 6, 21-8.
12. Senda, K., Arakawa, Y., Nakashima, K., Ito, H., Ichiyama, S., Shimokata, K. et al. (1996). Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapanems. Antimicrobial Agents and Chemotherapy 40, 349-53.
13. IMP among clinically isolated strains of Serratia marcescens. Antimicrobial Agents and Chemotherapy 39, 824-9.
14. Yamaguchi, H., Nukuga, M. & Sawai, T. (1994). Appearance of an R plasmid-mediated metallo β-lactamase in Gram-negative enteric bacteria. DNA Data Base of Japan (DDBJ) entry name KPNRD4; accession number D29636.
15. IMP. Antimicrobial Agents and Chemotherapy 39, 1612-5.
16. Paton, R., Miles, R. S., Hood, J. & Amyes, S. G. B. (1993). ARI-1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. International Journal of Antimicrobial Agents 2, 81-8.
17. Scaife, W., Young, H.-K., Paton, R. H. & Amyes, S. G. B. (1995). Transferable imipenem-resistance in Acinetobacter species from a clinical source. Journal of Antimicrobial Chemotherapy 36, 585-6.
18. Brown, S., Bantar, C., Young, H. & Amyes, S. G. B. (1996). An outbreak of imipenem resistance in Acinetobacter strains from Buenos Aires, Argentina. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1996. Abstract C122, p. 56. American Society for Microbiology, Washington, DC.
19. Costa, S. F., Wodcock, J., Child, J., Caiaffa, H. H., Gill, M., Wise, R. et al. (1996). Characterization of the β-lactamase and outer-membrane proteins of imipenem-resistant Acinetobacter baumannii clinical isolates from Brazil. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1996. Abstract C123, p. 56. American Society for Microbiology, Washington, DC.
20. Perez, A. N., Bonet, I. G., Robledo, E. H., Abascal, R. D. S. & Pious, C. V. (1996). Metallo-β-lactamases in Acinetobacter calcoaceticus? Medical Science Research 24, 315-7.
21. Urban, C., Go, E., Mariano, N. & Rahal, J. J. (1995). Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and -susceptible Acinetobacter baumannii. FEMS Microbiology Letters 125, 193-7.
22. Gehrlein, M., Leying, H., Cullmann, W., Wendt, S. & Opferkuch, W. (1991). Imipenem resistance in Acinetobacter baumannii is due to altered penicillin-binding proteins. Chemotherapy (Basle) 37, 405-12.
23. Spratt, B. G. (1994). Resistance to antibiotics mediated by target alterations. Science 264, 388-93.
24. Vivian, A. (1991). Genetic organisation of Acinetbacter. In The Biology of Acinetobacter: Taxonomy, Clinical Importance, Molecular Biology, Physiology, Industrial Relevance (Towner, K. J., Bergogne-Bérézin, E. & Fewson, C. A., Eds), pp. 191-200. Plenum Press, New York, NY.
25. Bergogne-Bérézin, E. & Joly-Guillou, M. L. (1991). Antibiotic resistance mechanisms in Acinetobacter. In The Biology of Acinetobacter: Taxonomy, Clinical Importance, Molecular Biology, Physiology, Industrial Relevance (Towner, K. J., Bergogne-Bérézin, E. & Fewson, C. A., Eds), pp. 83-115. Plenum Press, New York, NY.
26. Yang, Y. J., Wu, P. J. & Livermore, D. M. (1990). Biochemical characterization of a β-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Antimicrobial Agents and Chemotherapy 34, 755-8.
27. Naas, T., Vandel, L., Sougakoff, W., Livermore, D. M. & Nordmann, P. (1994). Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrobial Agents and Chemotherapy 38, 1262-70.
28. Rasmussen, B. A., Bush, K., Keeney, D., Yang, Y., Hare, R., O'Gara, C. et al. (1996). Characterization of IMI-1 β-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 40, 2080-6.
29. Nordmann, P., Mariette, S., Naas, T., Labia, R. & Nicolas, M. H. (1993). Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrobial Agents and Chemotherapy 37, 939-16.
30. Naas, T. & Nordmann, P. (1994). Analysis of a carbapenem-hydrolyzing class A β-lactamases from Enterobacter cloacae and of its LysR-type regulatory protein. Proceedings of the National Academy of Science of the USA 91, 7693-7.
31. Naas, T., Livermore, D. M. & Nordmann, P. (1995). Characterization of a LysR family protein, SmeR from Serralia marcescens S6, its effect on expression of the carbapenem-hydrolyzing β-lactamase Sme-1, and comparison of this regulator with other β-lactamase regulators. Antimicrobial Agents and Chemotherapy 39, 629-37.
32. Payne, D., Bateson, J., Gasson, B., Proctor, D., Khushi, T., Farmer, T. et al. (1996). Inhibition of metallo-β-lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrobial Agents and Chemotherapy 41, 135-40.